Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT02588677 · COMPLETED
Trial details
- NCT number
- NCT02588677
- Sponsor
- AB Science
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-12-05
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.